Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Novo Nordisk A/S

11 clinical trials · 11 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Novo Nordisk A/S

RECRUITINGPhase 3NCT06200207

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and...

The study is being done to see if ziltivekimab can be used to treat participants living with heart failure and inflammation. Participants will either get ziltivekimab (active...

Sponsor: Novo Nordisk A/SEnrolling: 68020 locations
Heart FailureSystemic Inflammation
RECRUITINGPhase 3NCT06118281

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development...

Sponsor: Novo Nordisk A/SEnrolling: 1000020 locations
Cardiovascular RiskAcute Myocardial Infarction (AMI)
RECRUITINGNCT07160816

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated...

Sponsor: Novo Nordisk A/SEnrolling: 24520 locations
Diabetes Mellitus, Type 1
RECRUITINGPhase 4NCT07112339

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in...

This study compares insulin icodec, taken once a week, with other basal insulins, taken once a day, in people with type 2 diabetes.The purpose of this study is to see how well the...

Sponsor: Novo Nordisk A/SEnrolling: 58620 locations
Diabetes Mellitus, Type 2
RECRUITINGNCT06269120

SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight,...

Participant will get oral semaglutde as prescribed by the study doctor. The study will last for about 26 ± 4 weeks (5 to 7 months). Participant will be asked to complete a...

Sponsor: Novo Nordisk A/SEnrolling: 4701 location
Type 2 Diabetes
RECRUITINGPhase 1NCT06891365

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of NNC0581-0001 in participants with hepatic steatosis and suspected steatohepatitis...

Sponsor: Novo Nordisk A/SEnrolling: 481 location
Healthy VolunteersHepatic Steatosis
RECRUITINGPhase 3NCT06612268

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

This study is conducted to confirm whether etavopivat works well at reducing the number of Vaso-occlusive crisis VOCs (sickle cell pain crises) caused by obstructions in blood...

Sponsor: Novo Nordisk A/SEnrolling: 40820 locations
Sickle Cell Disease
RECRUITINGPhase 1NCT07220564

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

This study will test how different doses of study medicine (Inno8) work in the bodies of people with haemophilia A. The purpose of the study is to see if Inno8 is safe to use for...

Sponsor: Novo Nordisk A/SEnrolling: 3020 locations
Haemophilia A
RECRUITINGNCT06574984

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

The study has descriptive purposes, with aim of assessing how turoctocog alfa is used in the everyday practice and to provide a baseline for the management of haemophilia A and...

Sponsor: Novo Nordisk A/SEnrolling: 9007 locations
Congenital Bleeding DisorderHaemophilia A
RECRUITINGPhase 1NCT07238816

A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People

The purpose of this study is to test a new medicine called Inno8. The study will test how eating and drinking before and after taking Inno8 affects how well it is absorbed in the...

Sponsor: Novo Nordisk A/SEnrolling: 801 location
Haemophilia A
RECRUITINGNCT05621746

An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

This study will collect information on the long term health of joints in people with haemophilia A who have started treatment with Esperoct within twelve months prior to...

Sponsor: Novo Nordisk A/SEnrolling: 1001 location
Haemophilia A